Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Targeted Therapies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05816642
What this trial is testing

Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
RenJi Hospital 500
Testing effectiveness (Phase 2)Study completedNCT02091141
What this trial is testing

My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors

Who this might be right for
NeoplasmsSolid TumorsBiliary Cancer+2 more
Genentech, Inc. 673
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06523049
What this trial is testing

Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy

Who this might be right for
Renal Cell CarcinomaImmunotherapyMolecular Targeted Therapy
Hao Zeng 67
Testing effectiveness (Phase 2)Ended earlyNCT04585815
What this trial is testing

Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 34
Not applicableEnded earlyNCT00898742
What this trial is testing

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 58
Not applicableUnknownNCT01652560
What this trial is testing

Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy

Who this might be right for
Breast CancerBevacizumabNeoadjuvant Chemotherapy+1 more
LiNanlin,Ph.D, Chief Physician,Clinical Professor 50
Not applicableStudy completedNCT06376773
What this trial is testing

Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping.

Who this might be right for
Advanced Gastric CancerNeoadjuvant TherapyMulti-omics Analysis
Fujian Medical University 234
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07715565
What this trial is testing

Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)ImmunotherapyMolecular Targeted Therapy
West China Hospital 66
Not applicableLooking for participantsNCT06669377
What this trial is testing

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 444
Testing effectiveness (Phase 2)Looking for participantsNCT05159245
What this trial is testing

The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs

Who this might be right for
Advanced CancerSolid TumorHaematological Malignancy
Helsinki University Central Hospital 250
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06848439
What this trial is testing

Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer

Who this might be right for
Mouth NeoplasmsNeoadjuvant TherapyImmunotherapy+1 more
Jiangsu Cancer Institute & Hospital 26
Early research (Phase 1)UnknownNCT02800369
What this trial is testing

Study of Molecular-targeted Therapy Using Zinc Finger Nuclease in Cervical Precancerous Lesions

Who this might be right for
Human Papillomavirus-Related Malignant Neoplasm
Huazhong University of Science and Technology 20
Testing effectiveness (Phase 2)Study completedNCT04045613
What this trial is testing

Derazantinib and Atezolizumab in Patients With Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Basilea Pharmaceutica 95
Not applicableStudy completedNCT05332496
What this trial is testing

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 941
Testing effectiveness (Phase 2)Looking for participantsNCT05332561
What this trial is testing

Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)

Who this might be right for
Early-stage Breast Cancer
German Cancer Research Center 240
Early research (Phase 1)Looking for participantsNCT06253871
What this trial is testing

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Who this might be right for
HER2 Mutation-Related TumorsHER2HER2-positive Breast Cancer+10 more
Iambic Therapeutics, Inc 383
Not applicableStudy completedNCT02315755
What this trial is testing

Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC

Who this might be right for
Renal Cell Carcinoma
Pfizer 102
Testing effectiveness (Phase 2)Study completedNCT01827384
What this trial is testing

MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations

Who this might be right for
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI) 208
Large-scale testing (Phase 3)Active Not RecruitingNCT04521153
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmunotherapyMolecular Targeted Therapy
Shanghai Zhongshan Hospital 294
Not applicableNot Yet RecruitingNCT06028178
What this trial is testing

Droplet Digital PCR Combines With Transcriptome Analysis in Early Warning of Sepsis in the Emergency Department

Who this might be right for
SepsisEmergent Infections, Treatment
Shanghai East Hospital 360
Next Page